Genprex, Inc. Soared
Thu, Feb 13, 2020 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) rocketted at $2.74, representing a gain of 51.4%. The stock appeared on our News Catalysts scanner on Tue 11 Feb 20 at 02:17 PM in the 'AGREEMENT' category. From Thu 23 Jan 20, the stock recorded 50.00% Up Days and 46.67% Green Days
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- FTS International, Inc. (FTSI:NYSE), 126.9%
- Genprex, Inc. (GNPX:NASDAQ), 51.38%
- Atlas Financial Holdings, Inc. (AFH:NASDAQ), 38.15%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.52%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 26.19%
- Northern Dynasty Minerals Ltd. (NAK:NYSEMKT), 25.53%
- Viveve Medical, Inc. (VIVE:NASDAQ), 24.51%
- Happiness Biotech Group Limited (HAPP:NASDAQ), 23.14%
- CounterPath Corporation (CPAH:NASDAQ), 21.86%
- EuroDry Ltd. (EDRY:NASDAQ), 21.15%